 I'm Eleanor Thompson and I'm one of the lecturers in the School of Science and I'm particularly interested in photosynthesis and that work has resulted in us getting a grant, getting some research money to fund solar panels in agriculture in Kent. So the campus is in the garden of England and we have links with a big soft fruit farm here who are helping us experiment with some agrivoltaics and what that means is solar panels that are used in agriculture. So we did some research recently looking at the effect of transparent solar panels on plant growth and now we have this big grant to put solar panels in an actual farm setting. So we have a partnership with a solar panel company and with a farm and in particular we're looking at the effect of solar panels, transparent solar panels installed on glass houses or on poly tunnels where we're growing soft fruit. So what you can see here is the solar yield, the electrical yield over the course of today on the glass house at the big fruit farm. So this is really addictive data that comes out of these remote loggers every day and we can do this on campus as well. So we have research students who are working on the project as well as the workers at the farm and they're looking at the effect of light on more experimental plants on campus as well as this commercial set of plants at the farm. So the reason for this project is that farms need to reduce their carbon footprint so they need to reduce the amount of fuel that they use and they want to get an electrical yield from solar panels so that they can run worker housing, irrigation, all of the automated systems that they have on farms. We're really interested in applying robotics more in farms so hopefully if you've got all of these solar panels installed at a farm you can use them for your many needs at the farm. The thing that's different about this grant is we're using transparent solar panels over glass houses or over poly tunnels or on walls of glass houses so we can see how you install them on structures that are already present so the farm doesn't have to buy a new glass house in order to have solar power on the farm. The University of Greenwich has a lot of plant growth expertise, crop expertise and I kind of come in at the edge of this at the photosynthesis side of things so I'm really interested in the effect on plants of changing the conditions that they're grown in but other people involved in the grant are really interested in the application of the solar panels and we have many members of staff who find this project useful and interesting because they want to apply post harvest technology, use the power from solar panels on the farm to do chilling or processing of foods. Hi, I'm Kevin Lamb and my research group here at the University of Greenwich is working on developing novel methods for transforming chemicals into other chemicals but instead of using toxic and expensive reagents we are mainly using electricity on one of the devices we are using. We have basically replaced toxic and as I said expensive chemicals by simple to electrodes and we are using electricity to achieve quite challenging transformations are not actually possible using normal chemical methods. We are really working across the fields, we are not only dealing with transformation of organic molecules we deal also with anti-cancer research still using our knowledge in the field to develop greener methods to develop anti-cancer reagents and recently we have also been involved with the European Union in developing methods to work on producing green hydrogen and coupled that to the development of anti-cancer drugs and order bioactive compounds by using electricity and I really, really invite you to get in touch with the university if you are really interested in what we are doing and would like hopefully to join us in the future. So my name is Cyril Cacou, I'm a first year PhD in the University of Greenwich and I'm originally from France. So I've heard a bit about Kevin Land research and back in France and so I decided to come here to follow my PhD program. So I'm working on electroactive compounds along with Professor Kevin Land. So I've joined Professor Kevin Land because he was working on pharmaceutical compounds and my hope in the future is to work into a pharmaceutical industry to make more drugs and using the way of electrochemistry we can do cheaper drugs and as well a greener work. Hello, I'm Professor Daniel Durumys at the University of Greenwich and I'm a professor in pharmaceutical technology and process engineering. Our research focuses on 3D printing technologies and applications for healthcare. A major part of our research lies on the development of pills for what we call personalized medication. So practically the design and development of pills can be adjusted to meet the individual needs of each patient. As an effect that this will have an improved clinical performance for the patients and they will improve their treatment but also the quality of life. So this is very important because we can adjust the amount of drug substance and also we can customize the release of the drug in our body. We also work with large pharmaceutical companies for the introduction of these technologies at the point of care mainly hostels and pharmacists. So eventually in the near future the patient will consult with our clinicians and then they would be able to collect the medication from the pharmacy store or the hostel. Another part of our research focuses on the development of medical devices. For example, we design and print drug-alluding stents and stents are used to open the arteries when they are blocked. Currently the commercial stents are comprised of metals or alloys and once they open the artery they will remain in our body forever. So the constant behind the 3D printing stents is to actually print polymeric stents which are strong enough to maintain the artery open and after a couple of years they will disappear from the body because they are but incredible. Another area of our work is to print what we call micro-needle arrays. So these are tiny needle arrays which are very small, less than 1mm and they can effectively pierce the skin without causing any pain, without damaging the skin but also they don't hit any nerves. As a result they can be used as a platform to administrate a lot of different drug substances through the skin which is the largest organ of our body. So recently we use micro-needs to administrate initially for diabetic patients in order to avoid skin damage because of the repeated use and also for people that are afraid of needles so they don't adhere to their medication. In a clinical trial we found that these micro-needs can administrate insulin quite effectively and have equal or even better clinical results compared to the subcutaneous injections that we use at the moment. So briefly this is our research at the University of Greenwich and what we do in our 3D printing lab. Thank you.